Regarding treatment, the percentage of patients with HNF1B-MODY treated with insulin was significantly higher than that of patients with HNF4A-MODY when compared with patients with T1DM (median 65.7% versus 36.4%, P = 0.00001 each). This evidence concerns the gene INS and type 1 diabetes mellitus.